2-Chloro-1-[4-(2,4-dimethylbenzenesulfonyl)piperazin-1-yl]ethan-1-one

Catalog No.: 
ACCZCS317
CAS No.: 
731012-06-9
Molecular Formula: 
C14H19ClN2O3S
Molecular Weight: 
330.84
2-Chloro-1-[4-(2,4-dimethylbenzenesulfonyl)piperazin-1-yl]ethan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$75.00InquiryInquiry
100mg95%$108.00InquiryInquiry
250mg95%$148.00InquiryInquiry
1g95%$371.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-1-[4-(2,4-dimethylbenzenesulfonyl)piperazin-1-yl]ethan-1-one
IUPAC Name2-chloro-1-(4-((2,4-dimethylphenyl)sulfonyl)piperazin-1-yl)ethan-1-one
MDL No.MFCD04626524
Molecular FormulaC14H19ClN2O3S
Molecular Weight330.84
SMILESO=C(N1CCN(S(=O)(C2=CC=C(C)C=C2C)=O)CC1)CCl
InChI KeyOZQJDRSVQWLSCY-UHFFFAOYSA-N
SynonymEthanone, 2-chloro-1-[4-[(2,4-dimethylphenyl)sulfonyl]-1-piperazinyl]-;2-Chloro-1-(4-((2,4-dimethylphenyl)sulfonyl)piperazin-1-yl)ethan-1-one
CAS No.731012-06-9

Synthetic Route by SureRoute

1. ACCZCS317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCZCS317 route product structure diagram
    ACCZCS317731012-06-9
Inquiry

2. ACCZCS317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCZCS317 route product structure diagram
    ACCZCS317731012-06-9
Inquiry

3. ACCZCS317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCZCS317 route product structure diagram
    ACCZCS317731012-06-9
Inquiry

Comments (0)